---
schema_version: "secwatch.filing_event.v1"
accession: "0000320017-22-000094"
form_type: "8-K"
ticker: "LSTA"
cik: "0000320017"
company_name: "LISATA THERAPEUTICS, INC."
filed_at: "2022-09-29T23:59:59+00:00"
generated_at: "2026-06-23T06:50:22.940330+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Lisata regains Nasdaq minimum bid price compliance; delisting risk removed

## Summary
- Received Nasdaq deficiency letter on Feb 18, 2022 for bid price below $1.00.
- Granted initial 180-day period ending Aug 17, 2022, then second period to Feb 13, 2023.
- On Sept 29, 2022, notified compliance regained after 10 consecutive days at $1.00+.
- Nasdaq confirmed the matter is now closed.
- Stock ticker LSTA remains listed on Nasdaq Capital Market.

## SEC filing metadata
- accession: 0000320017-22-000094
- form_type: 8-K
- ticker: LSTA
- cik: 0000320017
- company_name: LISATA THERAPEUTICS, INC.
- filed_at: 2022-09-29T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/320017/000032001722000094/0000320017-22-000094-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/320017/000032001722000094/clbs-20220929.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000320017-22-000094
- JSON: https://secwatch.observer/filing/0000320017-22-000094.json
- Plain text: https://secwatch.observer/filing/0000320017-22-000094.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.